Truist Financial Corp Has $126.93 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Truist Financial Corp grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.3% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 256,292 shares of the medical equipment provider's stock after acquiring an additional 8,200 shares during the quarter. Truist Financial Corp owned about 0.07% of Intuitive Surgical worth $126,934,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of ISRG. Atala Financial Inc bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $25,000. Parvin Asset Management LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $26,000. Global Financial Private Client LLC lifted its position in shares of Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after acquiring an additional 38 shares during the period. Hurley Capital LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $28,000. Finally, Summit Securities Group LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $30,000. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent analyst reports. Truist Financial cut their target price on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. Royal Bank Of Canada dropped their price objective on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Piper Sandler dropped their price objective on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a "hold" rating to a "sell" rating and dropped their price objective for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. Finally, Evercore ISI dropped their price objective on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research report on Wednesday, April 23rd. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and a consensus target price of $588.95.

Intuitive Surgical Stock Up 0.6%

Intuitive Surgical stock traded up $3.14 during trading hours on Friday, hitting $543.74. The stock had a trading volume of 704,815 shares, compared to its average volume of 1,672,707. The stock has a market cap of $194.89 billion, a price-to-earnings ratio of 79.73, a P/E/G ratio of 5.78 and a beta of 1.64. Intuitive Surgical, Inc. has a one year low of $413.82 and a one year high of $616.00. The business's 50 day simple moving average is $537.11 and its 200-day simple moving average is $536.76.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter in the prior year, the firm posted $1.50 earnings per share. Research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling

In other news, EVP Gary Loeb sold 1,700 shares of the stock in a transaction dated Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the sale, the executive vice president owned 2,245 shares of the company's stock, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total value of $96,991.08. Following the completion of the sale, the executive vice president directly owned 5,224 shares of the company's stock, valued at approximately $2,695,113.84. The trade was a 3.47% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 4,998 shares of company stock worth $2,611,577. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.